IDEX Corp free cash flow rises 21% to USD 189.8 million in Q4

Reuters
Feb 04
<a href="https://laohu8.com/S/IEX">IDEX Corp</a> free cash flow rises 21% to USD 189.8 million in Q4

IDEX Corporation reported financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2025. In Q4 2025, IDEX Corporation posted net sales of USD 899.1 million and a gross profit of USD 387.1 million. Selling, general and administrative expenses for the quarter were USD 201.1 million, while restructuring expenses and asset impairments totaled USD 2.4 million. The company reported an adjusted EBITDA margin of 26.8% in Q4 2025. Adjusted diluted EPS attributable to IDEX Corporation for the quarter was USD 2.10. Free cash flow reached USD 189.8 million, with a free cash flow conversion rate of 121%. For the full year 2025, IDEX Corporation reported net sales of USD 3.46 billion and a gross profit of USD 1.54 billion. Selling, general and administrative expenses for the year were USD 818.8 million, and restructuring expenses and asset impairments were USD 20.7 million. The adjusted EBITDA margin for the full year was 26.8%. Adjusted diluted EPS attributable to IDEX Corporation for FY 2025 was USD 7.95. Free cash flow for the year was USD 616.8 million, resulting in a free cash flow conversion rate of 103%. IDEX Corporation operates through three primary business segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products. The company designs and manufactures engineered components and applied solutions for critical industries, including satellite communications, water systems, medical diagnostics, and emergency rescue tools. IDEX Corporation comprises more than 50 businesses worldwide, with manufacturing operations in over 20 countries, and continues to focus on developing solutions that contribute to advances in modern life.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEX Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260204940450) on February 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10